Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
RTA 408-d3, is the labeled analogue of RTA 408 (R700990), which are antioxidant inflammation modulator (AIM) that can inhibit tumor cell growth and metastasis via oncogenic signaling pathways. RTA 408 is an anticancer, anti-inflammatory, and antioxidant agent that protects human retinal pigment epithelial cells against H2O2-induced cell injury by activating NF-E2-related factor 2.